CMS approves Watchman study for patients with nonvalvular atrial fibrillation

CMS recentlyapproved a randomized study to assess the Watchman device (Boston Scientific) in patients unsuitable for oral anticoagulation.

The FDA approved the Watchman left atrial appendage (LAA) closure device in March 2015 for patients with nonvalvular atrial fibrillation. The device is intended to reduce the risk of stroke in patients who want an alternative to warfarin or oral anticoagulants.

The post-approval study, known as ASAP-TOO, plans on enrolling 888 adults age 18 or older who will be randomized in a 2:1 ratio to receive the Watchman device or receive treatment with zero or one antiplatelet medications.

All patients will have nonvalvular atrial fibrillation, be deemed unsuitable for oral anticoagulation and be deemed suitable to receive aspirin and clopidogrel following implantation with the Watchman device.

The primary safety endpoint is the seven-day combined rate of death, ischemic stroke, systemic embolism and complications requiring major cardiovascular or endovascular intervention, while the primary efficacy endpoint is the comparison of time to first event of ischemic stroke and systemic embolism.

Boston Scientific plans on completing the study by December 2023.

In February 2016, CMS released its final national coverage determination for percutaneous left atrial appendage closure for non-valvular atrial fibrillation. The rule made the Watchman device available to certain Medicare patients.

The American College of Cardiology has also launched a registry to track data on left atrial appendage occlusion devices. The registry serves as the FDA-mandated post-approval study for the Watchman device.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup